Kristin Caltrider
Keine laufenden Positionen mehr
Vermögen: 41 391 $ am 31.03.2024
Profil
Kristin A.
Caltrider served as Vice President-Finance at Quidel Corp.
She then worked as Treasurer, Chief Financial & Accounting Officer at Inogen, Inc. Caltrider earned an undergraduate degree from California Lutheran University and an MBA from the University of San Diego.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
INOGEN, INC.
0,02% | 03.04.2023 | 5 129 ( 0,02% ) | 41 391 $ | 31.03.2024 |
Ehemalige bekannte Positionen von Kristin Caltrider
| Unternehmen | Position | Ende |
|---|---|---|
| INOGEN, INC. | Director of Finance/CFO | 11.09.2023 |
Quidel Corp.
 Quidel Corp. Medical SpecialtiesHealth Technology Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. The firm products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Ausbildung von Kristin Caltrider
| California Lutheran University | Undergraduate Degree |
| University of San Diego | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| INOGEN, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Quidel Corp.
Quidel Corp. Medical SpecialtiesHealth Technology Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. The firm products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA. | Health Technology |
